THERAPY WITH CERTOLIZUMAB PEGOL AND OTHER TNF-A INHIBITORS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE CORRONA REGISTRY

被引：0
|
作者：
Pappas, D. A.
Etzel, C. J. [1 ]
Bedenbaugh, A. [2 ]
Tambiah, J. [3 ]
Greenberg, J. D. [4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] UCB Pharma, Smyrna, GA USA
[3] UCB, Smyrna, GA USA
[4] NYU, Sch Med, New York, NY USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.256
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS11
引用
收藏
页码：A43 / A43
页数：1
相关论文
共 50 条
  • [41] Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study
    Saraux, A.
    Combe, B.
    Fagnani, F.
    Cukierman, G.
    Bru, I
    Joubert, J-M
    Schuller, J-C
    Massol, J.
    Flipo, R-M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 781 - 789
  • [42] Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios A.
    Kremer, Joel M.
    Griffith, Jenny
    Reed, George
    Salim, Bob
    Karki, Chitra
    Garg, Vishvas
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 375 - 389
  • [43] Certolizumab pegol monotherapy improves productivity in patients with active rheumatoid arthritis: results from a phase iii randomized controlled trial
    Strand, V.
    Brown, M.
    Purcaru, O.
    Richard, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 274 - 274
  • [44] Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study
    Weinblatt, Michael E.
    Fleischmann, Roy
    Huizinga, Tom W. J.
    Emery, Paul
    Pope, Janet
    Massarotti, Elena M.
    van Vollenhoven, Ronald F.
    Wollenhaupt, Juergen
    Bingham, Clifton O., III
    Duncan, Ben
    Goel, Niti
    Davies, Owen R.
    Dougados, Maxime
    RHEUMATOLOGY, 2012, 51 (12) : 2204 - 2214
  • [45] Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
    Dimitrios A. Pappas
    Joel M. Kremer
    Jenny Griffith
    George Reed
    Bob Salim
    Chitra Karki
    Vishvas Garg
    Rheumatology and Therapy, 2017, 4 : 375 - 389
  • [46] Real-World Consistency of Response to Adalimumab over Time in Patients with Rheumatoid Arthritis: Results from the Corrona Registry
    Pappas, Dimitrios A.
    Reed, George W.
    Karki, Chitra
    Griffith, Jenny
    Skup, Martha
    Garg, Vishvas
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry
    Mease, Philip J.
    Collier, David H.
    Saunders, Katherine C.
    Li, Guo
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    RMD OPEN, 2015, 1 (01):
  • [48] Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
    Kumar, Namita
    Naz, Sophia
    Quinn, Mark
    Ryan, John
    Kumke, Thomas
    Sheeran, Tom
    ADVANCES IN THERAPY, 2018, 35 (09) : 1426 - 1437
  • [49] Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study
    Miyazaki, Yusuke
    Nakano, Kazuhisa
    Nakayamada, Shingo
    Kubo, Satoshi
    Iwata, Shigeru
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Miyagawa, Ippei
    Yamaguchi, Ayako
    Kawabe, Akio
    Saito, Kazuyoshi
    Tanaka, Yoshiya
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [50] Longterm Followup of Rituximab Therapy in Patients with Rheumatoid Arthritis: Results from the Belgian MabThera in Rheumatoid Arthritis Registry
    De Keyser, Filip
    Hoffman, Ilse
    Durez, Patrick
    Kaiser, Marie-Joelle
    Westhovens, Rene
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (09) : 1761 - 1765
12345